对中美精准医学差异及我国精准医学发展的思考

The Difference of Sino-U.S.Precision Medicine and Its Implications for China

目前精准医学已经成为医学界的研究热点,美国和我国政府先后启动了精准医学相关科研项目的规划与部署。然而,中美精准医学在概念、目标及主要内容等方面存在差异。由于我国的基本国情及疾病谱与美国存在差异,因此,我国的精准医学概念更为广泛,在分子生物学基础上,还应将我国传统医学纳入精准医学的范畴。同时,我国的精准医学以提高医疗保健服务为目标,旨在建立世界一流的精准医学研究平台和保障体系,研发一系列具有我国自主知识产权的临床药物及医疗设备,进一步加快推进我国医疗卫生体制和医疗模式改革。在借鉴美国精准医学发展的成功经验的同时,更需结合我国实际情况,探索具有中国特色的精准医学之路。

Precision medicine has become a hot issue and a research focus in medical field. Both of the United States and China have launched the precision medicine research projects. However, due to the different basic national conditions and the different disease spectrum between the United States and China, the concept of precision medicine is more extensive in China. On the basis of molecular biology, Chinese precision medicine also includes the Traditional Chinese Medicine. At the same time, precision medicine in China aims at improving health care services, building a world-class precision medical research platform and support system, developing a series of clinical medicine and medical equipment with Chinese independent intellectual property, accelerating the reforms of health care system and medical model in China. This paper illustrated the differences of precision medicine in connotations, targets and main contents between China and the United States, discussing the developing direction of precision medicine, so as to provide reference for the successful implementation of the precision medicine in China.